Research & Development

哥哥干嘛哥哥干哥哥陈雨露:深化金融供给侧改革 推动财富管理市场发展


  “閨女蹲不住了就告訴耶耶,耶耶接你下來。”   雲瑯見東方朔還在遠處,就小聲在曹襄耳邊道︰“去病他們在三天前的夜晚,突襲了八胡校尉營地。”哥哥干嘛   “耶耶,公公拉我的腿,好痛。”哥哥干   雲瑯見劉徹還在沉思,就笑道︰“陛下如果不滿意,不妨再出題,畢竟《美人歌》微臣已經作過一次,第二遍再作就需要避開前意,受到了一些限制,不如第一遍美。”   “江碧鳥逾白,山青花欲燃。今春看又過,何日是歸年。”哥哥   甦稚一進門就躲在雲瑯的背後,看都不敢看宋喬一眼。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo